Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001061983-22-000077
Filing Date
2022-03-15
Accepted
2022-03-15 19:34:41
Documents
1
Period of Report
2022-03-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 13148
  Complete submission text file 0001061983-22-000077.txt   14512
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Issuer) CIK: 0001061983 (see all company filings)

EIN.: 943291317 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IMPAX LABORATORIES, INC. 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address
SCHLOSSBERG MARK A (Reporting) CIK: 0001520533 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50633 | Film No.: 22742838